A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group
Abstract
:Simple Summary
Abstract
1. Introduction
2. Materials and Methods
2.1. Data Origin and Search Strategy
2.2. Data Analysis
3. Results
3.1. Overview
3.2. Themes and Trends
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Palma, D.A.; Salama, J.K.; Lo, S.S.; Senan, S.; Treasure, T.; Govindan, R.; Weichselbaum, R. The Oligometastatic State—Separating Truth from Wishful Thinking. Nat. Rev. Clin. Oncol. 2014, 11, 549–557. [Google Scholar] [CrossRef] [PubMed]
- Guckenberger, M.; Lievens, Y.; Bouma, A.B.; Collette, L.; Dekker, A.; de Souza, N.M.; Dingemans, A.-M.C.; Fournier, B.; Hurkmans, C.; Lecouvet, F.E.; et al. Characterisation and Classification of Oligometastatic Disease: A European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer Consensus Recommendation. Lancet Oncol. 2020, 21, e18–e28. [Google Scholar] [CrossRef] [Green Version]
- AlGhamdi, H.; Dhont, J.; Krayem, M.; De Bruyn, P.; Engels, B.; Van Gestel, D.; Van den Begin, R. The Road to Dissemination: The Concept of Oligometastases and the Barriers for Widespread Disease. Cancers 2022, 14, 2046. [Google Scholar] [CrossRef] [PubMed]
- Treasure, T. Oligometastatic Cancer: An Entity, a Useful Concept, or a Therapeutic Opportunity? J. R. Soc. Med. 2012, 105, 242–246. [Google Scholar] [CrossRef] [PubMed]
- Hendriks, L.E.L.; Dooms, C.; Berghmans, T.; Novello, S.; Levy, A.; De Ruysscher, D.; Hasan, B.; Giaj Levra, M.; Giaj Levra, N.; Besse, B.; et al. Defining Oligometastatic Non-Small Cell Lung Cancer: A Simulated Multidisciplinary Expert Opinion. Eur. J. Cancer 2019, 123, 28–35. [Google Scholar] [CrossRef] [Green Version]
- Schanne, D.H.; Heitmann, J.; Guckenberger, M.; Andratschke, N.H.J. Evolution of Treatment Strategies for Oligometastatic NSCLC Patients—A Systematic Review of the Literature. Cancer Treat. Rev. 2019, 80, 101892. [Google Scholar] [CrossRef]
- Marvaso, G.; Volpe, S.; Pepa, M.; Zaffaroni, M.; Corrao, G.; Augugliaro, M.; Nolè, F.; De Cobelli, O.; Jereczek-Fossa, B.A. Recent Advances in the Management of Hormone-Sensitive Oligometastatic Prostate Cancer. CMAR 2022, 14, 89–101. [Google Scholar] [CrossRef] [PubMed]
- Fraser, M.; Koontz, B.; Emmenegger, U.; De Meerleer, G.; Khoo, V.; Feng, F.; Corcoran, N.M.; Hovens, C.M.; Tran, P.T.; Ost, P.; et al. What Is Oligometastatic Prostate Cancer? Eur. Urol. Focus 2019, 5, 159–161. [Google Scholar] [CrossRef]
- Piroth, M.D.; Krug, D.; Feyer, P.; Baumann, R.; Combs, S.; Duma, M.-N.; Dunst, J.; Fastner, G.; Fietkau, R.; Guckenberger, M.; et al. Oligometastasis in Breast Cancer—Current Status and Treatment Options from a Radiation Oncology Perspective. Strahlenther. Onkol. 2022, 198, 601–611. [Google Scholar] [CrossRef]
- Miglietta, F.; Visani, L.; Marini, S.; Griguolo, G.; Vernaci, G.M.; Bottosso, M.; Dieci, M.V.; Meattini, I.; Guarneri, V. Oligometastatic Breast Cancer: Dissecting the Clinical and Biological Uniqueness of This Emerging Entity. Can We Pursue Curability? Cancer Treat. Rev. 2022, 110, 102462. [Google Scholar] [CrossRef]
- Vietti Violi, N.; Hajri, R.; Haefliger, L.; Nicod-Lalonde, M.; Villard, N.; Dromain, C. Imaging of Oligometastatic Disease. Cancers 2022, 14, 1427. [Google Scholar] [CrossRef]
- Beckham, T.H.; Yang, T.J.; Gomez, D.; Tsai, C.J. Metastasis-Directed Therapy for Oligometastasis and Beyond. Br. J. Cancer 2021, 124, 136–141. [Google Scholar] [CrossRef]
- Marvaso, G.; Volpe, S.; Pepa, M.; Augugliaro, M.; Corrao, G.; Biffi, A.; Zaffaroni, M.; Bergamaschi, L.; La Fauci, F.M.; Mistretta, F.A.; et al. Oligorecurrent Prostate Cancer and Stereotactic Body Radiotherapy: Where Are We Now? A Systematic Review and Meta-Analysis of Prospective Studies. Eur. Urol. Open Sci. 2021, 27, 19–28. [Google Scholar] [CrossRef] [PubMed]
- Marvaso, G.; Corrao, G.; Oneta, O.; Pepa, M.; Zaffaroni, M.; Corso, F.; Gandini, S.; Cecconi, A.; Zerini, D.; Mazzola, G.C.; et al. Oligo Metastatic Renal Cell Carcinoma: Stereotactic Body Radiation Therapy, If, When and How? Clin. Transl. Oncol. 2021, 23, 1717–1726. [Google Scholar] [CrossRef] [PubMed]
- Zaorsky, N.G.; Lehrer, E.J.; Kothari, G.; Louie, A.V.; Siva, S. Stereotactic Ablative Radiation Therapy for Oligometastatic Renal Cell Carcinoma (SABR ORCA): A Meta-Analysis of 28 Studies. Eur. Urol. Oncol. 2019, 2, 515–523. [Google Scholar] [CrossRef] [PubMed]
- Ost, P.; Reynders, D.; Decaestecker, K.; Fonteyne, V.; Lumen, N.; De Bruycker, A.; Lambert, B.; Delrue, L.; Bultijnck, R.; Claeys, T.; et al. Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial. JCO 2018, 36, 446–453. [Google Scholar] [CrossRef] [Green Version]
- Kent, C.L.; McDuff, S.G.R.; Salama, J.K. Oligometastatic Breast Cancer: Where Are We Now and Where Are We Headed?—A Narrative Review. Ann. Palliat. Med. 2021, 10, 5954–5968. [Google Scholar] [CrossRef]
- Hellman, S.; Weichselbaum, R.R. Oligometastases. JCO 1995, 13, 8–10. [Google Scholar] [CrossRef]
- Aria, M.; Cuccurullo, C. Bibliometrix: An R-Tool for Comprehensive Science Mapping Analysis. J. Informetr. 2017, 11, 959–975. [Google Scholar] [CrossRef]
- Lancichinetti, A.; Fortunato, S.; Kertész, J. Detecting the Overlapping and Hierarchical Community Structure in Complex Networks. New J. Phys. 2009, 11, 033015. [Google Scholar] [CrossRef]
- Aria, M.; Cuccurullo, C.; D’Aniello, L.; Misuraca, M.; Spano, M. Thematic Analysis as a New Culturomic Tool: The Social Media Coverage on COVID-19 Pandemic in Italy. Sustainability 2022, 14, 3643. [Google Scholar] [CrossRef]
- Cuccurullo, C.; Aria, M.; Sarto, F. Foundations and Trends in Performance Management. A Twenty-Five Years Bibliometric Analysis in Business and Public Administration Domains. Scientometrics 2016, 108, 595–611. [Google Scholar] [CrossRef]
- Greenacre, M.; Blasius, J. (Eds.) Multiple Correspondence Analysis and Related Methods; CRC: Boca Raton, FL, USA, 2006; ISBN 978-1-4200-1131-9. [Google Scholar]
- Palma, D.A.; Olson, R.; Harrow, S.; Gaede, S.; Louie, A.V.; Haasbeek, C.; Mulroy, L.; Lock, M.; Rodrigues, G.B.; Yaremko, B.P.; et al. Stereotactic Ablative Radiotherapy versus Standard of Care Palliative Treatment in Patients with Oligometastatic Cancers (SABR-COMET): A Randomised, Phase 2, Open-Label Trial. Lancet 2019, 393, 2051–2058. [Google Scholar] [CrossRef] [PubMed]
- Gomez, D.R.; Blumenschein, G.R.; Lee, J.J.; Hernandez, M.; Ye, R.; Camidge, D.R.; Doebele, R.C.; Skoulidis, F.; Gaspar, L.E.; Gibbons, D.L.; et al. Local Consolidative Therapy versus Maintenance Therapy or Observation for Patients with Oligometastatic Non-Small-Cell Lung Cancer without Progression after First-Line Systemic Therapy: A Multicentre, Randomised, Controlled, Phase 2 Study. Lancet Oncol. 2016, 17, 1672–1682. [Google Scholar] [CrossRef] [Green Version]
- Gomez, D.R.; Tang, C.; Zhang, J.; Blumenschein, G.R.; Hernandez, M.; Lee, J.J.; Ye, R.; Palma, D.A.; Louie, A.V.; Camidge, D.R.; et al. Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients with Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study. JCO 2019, 37, 1558–1565. [Google Scholar] [CrossRef] [PubMed]
- Weickhardt, A.J.; Scheier, B.; Burke, J.M.; Gan, G.; Lu, X.; Bunn, P.A.; Aisner, D.L.; Gaspar, L.E.; Kavanagh, B.D.; Doebele, R.C.; et al. Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer. J. Thorac. Oncol. 2012, 7, 1807–1814. [Google Scholar] [CrossRef] [Green Version]
- Phillips, R.; Shi, W.Y.; Deek, M.; Radwan, N.; Lim, S.J.; Antonarakis, E.S.; Rowe, S.P.; Ross, A.E.; Gorin, M.A.; Deville, C.; et al. Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial. JAMA Oncol. 2020, 6, 650. [Google Scholar] [CrossRef] [Green Version]
- Weichselbaum, R.R.; Hellman, S. Oligometastases Revisited. Nat. Rev. Clin. Oncol. 2011, 8, 378–382. [Google Scholar] [CrossRef]
- Cunningham, D.; Atkin, W.; Lenz, H.-J.; Lynch, H.T.; Minsky, B.; Nordlinger, B.; Starling, N. Colorectal Cancer. Lancet 2010, 375, 1030–1047. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Marvaso, G.; Mastroleo, F.; Corrao, G.; Zaffaroni, M.; Vincini, M.G.; Borghetti, P.; Cuccia, F.; Federico, M.; Montesi, G.; Pontoriero, A.; et al. A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group. Cancers 2023, 15, 3902. https://doi.org/10.3390/cancers15153902
Marvaso G, Mastroleo F, Corrao G, Zaffaroni M, Vincini MG, Borghetti P, Cuccia F, Federico M, Montesi G, Pontoriero A, et al. A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group. Cancers. 2023; 15(15):3902. https://doi.org/10.3390/cancers15153902
Chicago/Turabian StyleMarvaso, Giulia, Federico Mastroleo, Giulia Corrao, Mattia Zaffaroni, Maria Giulia Vincini, Paolo Borghetti, Francesco Cuccia, Manuela Federico, Giampaolo Montesi, Antonio Pontoriero, and et al. 2023. "A Bibliometric Analysis of the Oligometastatic State over the Last Two Decades: A Shifting Paradigm for Oncology? An AIRO Oligometastatic Study Group" Cancers 15, no. 15: 3902. https://doi.org/10.3390/cancers15153902